Literature DB >> 15773917

Nuclear Ca2+ and CaM kinase IV specify hormonal- and Notch-responsiveness.

Grahame J McKenzie1, Patrick Stevenson, George Ward, Sofia Papadia, Hilmar Bading, Sangeeta Chawla, Martin Privalsky, Giles E Hardingham.   

Abstract

Many neuronal processes require gene activation by synaptically evoked Ca(2+) transients. Ca(2+)-dependent signal pathways activate some transcription factors outright, but here we report that such signals also potentiate the activation of nuclear receptors by their cognate hormone, and of CBF1 by Notch, transcription factors hitherto not thought to be Ca(2+)-responsive. This potentiation is occluded by histone deacetylase inhibition, indicating a mechanism involving inactivation of co-repressors associated with these transcription factors. Synaptic activity, acting via the nuclear Ca(2+)-dependent activation of CaM kinase IV, triggers the disruption of subnuclear domains containing class II histone deacetylases (HDACs) and silencing mediator of retinoic acid and thyroid hormone receptors (SMRT), a broad-specificity co-repressor which represses nuclear hormone receptors and CBF1. The sequential loss of class II HDACs and SMRT from the subnuclear domains, followed by nuclear export, is associated with disruption of SMRT interaction with its target transcription factors and sensitization of these factors to their activating signal. Counterbalancing these changes, protein phosphatase 1 promotes nuclear localization of SMRT and inactivation of nuclear receptors and CBF1. Thus, the synaptically controlled kinase-phosphatase balance of the neuron determines the efficacy of SMRT-mediated repression and the signal-responsiveness of a variety of transcription factors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15773917     DOI: 10.1111/j.1471-4159.2005.03010.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  34 in total

Review 1.  Translational regulation of neuronal electrical properties.

Authors:  Andrew J Weston; Richard A Baines
Journal:  Invert Neurosci       Date:  2007-01-13

2.  Notch signaling is essential for ventricular chamber development.

Authors:  Joaquín Grego-Bessa; Luis Luna-Zurita; Gonzalo del Monte; Victoria Bolós; Pedro Melgar; Alejandro Arandilla; Alistair N Garratt; Heesuk Zang; Yoh-Suke Mukouyama; Hanying Chen; Weinian Shou; Esteban Ballestar; Manel Esteller; Ana Rojas; José María Pérez-Pomares; José Luis de la Pompa
Journal:  Dev Cell       Date:  2007-03       Impact factor: 12.270

3.  Co-localization of the amyloid precursor protein and Notch intracellular domains in nuclear transcription factories.

Authors:  Uwe Konietzko; Zoë V Goodger; Michelle Meyer; Bernhard M Kohli; Jérôme Bosset; Debomoy K Lahiri; Roger M Nitsch
Journal:  Neurobiol Aging       Date:  2008-04-10       Impact factor: 4.673

4.  Notch and hippo converge on Cdx2 to specify the trophectoderm lineage in the mouse blastocyst.

Authors:  Teresa Rayon; Sergio Menchero; Andres Nieto; Panagiotis Xenopoulos; Miguel Crespo; Katie Cockburn; Susana Cañon; Hiroshi Sasaki; Anna-Katerina Hadjantonakis; Jose Luis de la Pompa; Janet Rossant; Miguel Manzanares
Journal:  Dev Cell       Date:  2014-08-07       Impact factor: 12.270

5.  Excitotoxic insults lead to peroxiredoxin hyperoxidation.

Authors:  Frédéric Léveillé; Francesc X Soriano; Sofia Papadia; Giles E Hardingham
Journal:  Oxid Med Cell Longev       Date:  2009 Apr-Jun       Impact factor: 6.543

Review 6.  Thyroid hormone and the brain: Mechanisms of action in development and role in protection and promotion of recovery after brain injury.

Authors:  Yan-Yun Liu; Gregory A Brent
Journal:  Pharmacol Ther       Date:  2018-02-09       Impact factor: 12.310

7.  Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy.

Authors:  Guillermo Luxán; Jesús C Casanova; Beatriz Martínez-Poveda; Belén Prados; Gaetano D'Amato; Donal MacGrogan; Alvaro Gonzalez-Rajal; David Dobarro; Carlos Torroja; Fernando Martinez; José Luis Izquierdo-García; Leticia Fernández-Friera; María Sabater-Molina; Young-Y Kong; Gonzalo Pizarro; Borja Ibañez; Constancio Medrano; Pablo García-Pavía; Juan R Gimeno; Lorenzo Monserrat; Luis J Jiménez-Borreguero; José Luis de la Pompa
Journal:  Nat Med       Date:  2013-01-13       Impact factor: 53.440

8.  Synaptic NMDAR activity suppresses FOXO1 expression via a cis-acting FOXO binding site: FOXO1 is a FOXO target gene.

Authors:  Bashayer Al-Mubarak; Francesc X Soriano; Giles E Hardingham
Journal:  Channels (Austin)       Date:  2009-07-24       Impact factor: 2.581

9.  Specific targeting of pro-death NMDA receptor signals with differing reliance on the NR2B PDZ ligand.

Authors:  Francesc X Soriano; Marc-Andre Martel; Sofia Papadia; Anne Vaslin; Paul Baxter; Colin Rickman; Joan Forder; Michael Tymianski; Rory Duncan; Michelle Aarts; Peter Clarke; David J A Wyllie; Giles E Hardingham
Journal:  J Neurosci       Date:  2008-10-15       Impact factor: 6.167

10.  New insights into the functions and regulation of the transcriptional corepressors SMRT and N-CoR.

Authors:  Kristopher J Stanya; Hung-Ying Kao
Journal:  Cell Div       Date:  2009-04-21       Impact factor: 5.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.